Expert Insights from Health IT Industry Analysts
The Chilmark Research blog is the foundation of the analyst firm. Weekly blogging is how our founder first established credibility in the industry all the way back in 2007, becoming a core platform for industry discussion and engagement since those early days. You can see how our subject matter experts are viewing developing technology use cases, the narratives surrounding their adoption and regulation, and engage with this coverage directly in the comments. Click through any of the articles below to see what’s new!
Is There Value in Twitter?
Certainly Wall St. sees value in Twitter with its share price sky-rocketing on first day of trading, but is there truly value in Twitter for us out there wandering the Internet ether? Simply put: Yes With the caveat, that you are cautious and go into it with clear...
Has Avado Acquisition Awakened the WebMD Giant
WebMD, the once-darling of consumer health who seemingly lost its way following pharma dollars, may at last be coming back to its roots. Last week, WebMD made headlines by announcing it had purchased the young patient engagement start-up, Avado, for an undisclosed...
Wellness Market: Too Many Chasing Too Little
Having taken a hiatus from last year's Health 2.0 event, was looking forward to this year's event to see what may be new and upcoming among those looking to disrupt the status quo. Unfortunately, surprisingly little. Health 2.0 a couple of weeks back had your usually...
Crashes, Bugs, and Major Usability Issues at Covered California
I have spent the past few days struggling to apply for insurance on California’s HIX, CoveredCA. Early on in the application process I tried to withhold judgment, but have since learned that coveredca.com has a price tag of $360M, awarded to Accenture. And so I am...
Data-Driven Patient Outreach: Financially Efficient or Morally Compromised?
I recently spoke with a clinical analytics vendor about one of their provider customer's bizarre decisions - to no longer encourage a subset of their diabetic population to take the HbA1C test. The reason? These diabetics were covered under a new P4P payment contract,...
Can Mirth Revive NextGen?
Last week, NextGen's parent company, QSI, acquired open-source tools vendor Mirth for $59M. While a relatively small acquisition, it nonetheless will have an impact on the broader HIE market. Mirth's toolset has an array of HIE components, notably its well-regarded...
Breaking New Ground
Today is a great day for Chilmark Research and hopefully the world of healthcare IT. At long last, the much anticipated Market Trends report Clinical Analytics for Population Health (CAPH) has been published. Coming in at slightly more than 100 pages with in-depth...
Haunted by the Past: The Legacy of Claims Data Continues
Assume for the moment that we are indeed looking towards a future of widespread value-based reimbursement and provider-led population health management (PHM). Claims data should come to be seen as increasingly irrelevant, right? This is what I initially assumed before...
Stretching it – Just a Bit
One of our objectives here at Chilmark Research is to provide clarity to the healthcare IT market sector. This is not always an easy task. Time and again we see vendors stretch the truth in the hopes that no one will call them out. Years ago, I wrote a post called...
Subscribe to the Chilmark Newsletter
Stay up to date with the latest healthcare IT news!